je.st
news
Tag: pharmaceuticals
RXi Pharmaceuticals Corp (RXII) Downgraded by Zacks Investment Research to "Sell"
2015-12-19 21:28:21| Biotech - Topix.net
According to Zacks, "RXi Pharmaceuticals Corporation is a biotechnology company focused on discovering, developing and commercializing therapies based on its RNAi platform. The Company is developing RXI-109, which is used for the reduction of dermal scarring in planned surgeries, as well as reduces the expression of connective tissue growth factor.
Tags: research
sell
investment
corp
Isis Pharmaceuticals changes name to Ionis
2015-12-18 18:21:18| Biotech - Topix.net
Isis Pharmaceuticals, which shares a name with the Islamic State extremist group, has changed its name to Ionis Pharmaceuticals after resisting to do so for some time. The drug developer says its old name was a distraction since it was associated with the Islamic State, which is commonly known by its acronym ISIS.
Tags: to
pharmaceuticals
isis
isis pharmaceuticals
Valeant Pharmaceuticals Intl's (VRX) Hold Rating Reiterated at Morgan Stanley
2015-12-16 07:40:59| Biotech - Topix.net
's stock had its "hold" rating reiterated by equities researchers at Morgan Stanley in a research note issued to investors on Tuesday, MarketBeat reports. Shares of Valeant Pharmaceuticals Intl traded up 16.41% during midday trading on Tuesday, reaching $109.59.
Tags: rating
hold
morgan
stanley
Ariad Pharmaceuticals Sees Large Decline in Short Interest
2015-12-01 11:52:29| Biotech - Topix.net
Shares of Ariad Pharmaceuticals were the recipient of a significant decline in short interest in the month of November. As of November 13th, there was short interest totalling 30,675,599 shares, a decline of 4.3% from the October 30th total of 32,043,531 shares, AnalystRatings.Net reports.
Tags: large
short
interest
decline
Vetr Inc. Upgrades Vertex Pharmaceuticals to Buy
2015-11-30 03:30:58| Biotech - Topix.net
The firm currently has a $137.08 price objective on the pharmaceutical company's stock. Vetr 's price objective would indicate a potential upside of 3.02% from the stock's previous close.
Tags: buy
upgrades
pharmaceuticals
vertex
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] next »